Mapping the protein-binding sites for novel iridium(III) anticancer complexes using electron capture dissociation

Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents

(2012) Stephanie J. Lucas et al.   DALTON TRANSACTIONS

Protein flexibility is key to cisplatin crosslinking in calmodulin

(2012) Huilin Li et al.   PROTEIN SCIENCE

Use of Top-Down and Bottom-Up Fourier Transform Ion Cyclotron Resonance Mass Spectrometry for Mapping Calmodulin Sites Modified by Platinum Anticancer Drugs

(2011) Huilin Li et al.   ANALYTICAL CHEMISTRY

Mass Spectrometry Evidence for Cisplatin As a Protein Cross-Linking Reagent

(2011) Huilin Li et al.   ANALYTICAL CHEMISTRY

The anticancer drug cisplatin can cross-link the interdomain zinc site on human albumin

(2011) Wenbing Hu et al.   CHEMICAL COMMUNICATIONS

Contrasting Reactivity and Cancer Cell Cytotoxicity of Isoelectronic Organometallic Iridium(III) Complexes

(2011) Zhe Liu et al.   INORGANIC CHEMISTRY

Organometallic Half-Sandwich Iridium Anticancer Complexes

(2011) Zhe Liu et al.   JOURNAL OF MEDICINAL CHEMISTRY

Organometallic Iridium(III) Cyclopentadienyl Anticancer Complexes Containing C,N-Chelating Ligands

(2011) Zhe Liu et al.   ORGANOMETALLICS

Electron Capture Dissociation Implementation Progress in Fourier Transform Ion Cyclotron Resonance Mass Spectrometry

(2008) Yury O. Tsybin et al.   JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY

Characterization of Platinum Anticancer Drug Protein-Binding Sites Using a Top-Down Mass Spectrometric Approach

(2007) Christian G. Hartinger et al.   INORGANIC CHEMISTRY